The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1547
May 21, 2018
View Complete Issue         Table of Contents 2019 
Clenpiq - A Low-Volume Sodium Picosulfate-Based Colonoscopy Preparation
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Clenpiq - A Low-Volume Sodium Picosulfate-Based Colonoscopy Preparation
May 21, 2018 (Issue: 1547)
The FDA has approved Clenpiq (Ferring), a low-volume oral solution that contains sodium picosulfate, magnesium oxide, and anhydrous citric acid, for colon cleansing prior to colonoscopy in adults. The ready-to-drink solution contains the same...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Clenpiq - A Low-Volume Sodium Picosulfate-Based Colonoscopy Preparation
Article code: 1547b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.